{
  "state": "georgia",
  "path": "title-title-33-insurance-ââ-33-1-1-â-33-66-8/chapter-chapter-53-coverage-for-certain-types-of-anti-cancer-drug-th",
  "sections": [
    {
      "id": "section-33-53-1",
      "number": "33-53-1",
      "heading": "DefinitionsSection 33-53-2 - Conditions of coverageSection 33-53-3 - [Reserved] EnforcementSection 33-53-4 - Exceptions to requirements for coverage",
      "text": "As used in this chapter:(1)\"Drug\" means a drug or biologic that is used in an antineoplastic regimen.(2)\"Insurance policy\" means an individual accident and sickness policy of insurance issued pursuant to Chapter 29 of this title or a group accident and sickness insurance policy issued pursuant to Chapter 30 of this title.(3)\"Standard reference compendium\" means any of the following:(A)The United States Pharmacopeia Drug Information;(B)The American Medical Association Drug Evaluations;(C)The American Hospital Formulary Service Drug Information.Amended by 2019 Ga. Laws 186,§ 1-15, eff. 7/1/2019.\n\nAs used in this chapter:(1)\"Drug\" means a drug or biologic that is used in an antineoplastic regimen.(2)\"Insurance policy\" means an individual accident and sickness policy of insurance issued pursuant to Chapter 29 of this title or a group accident and sickness insurance policy issued pursuant to Chapter 30 of this title.(3)\"Standard reference compendium\" means any of the following:(A)The United States Pharmacopeia Drug Information;(B)The American Medical Association Drug Evaluations;(C)The American Hospital Formulary Service Drug Information.Amended by 2019 Ga. Laws 186,§ 1-15, eff. 7/1/2019.\n\nAs used in this chapter:(1)\"Drug\" means a drug or biologic that is used in an antineoplastic regimen.(2)\"Insurance policy\" means an individual accident and sickness policy of insurance issued pursuant to Chapter 29 of this title or a group accident and sickness insurance policy issued pursuant to Chapter 30 of this title.(3)\"Standard reference compendium\" means any of the following:(A)The United States Pharmacopeia Drug Information;(B)The American Medical Association Drug Evaluations;(C)The American Hospital Formulary Service Drug Information.Amended by 2019 Ga. Laws 186,§ 1-15, eff. 7/1/2019.\n\nAs used in this chapter:\n\nAmended by 2019 Ga. Laws 186,§ 1-15, eff. 7/1/2019.",
      "history": "",
      "source_url": "https://law.justia.com/codes/georgia/title-33/chapter-53/section-33-53-1/"
    },
    {
      "id": "section-33-53-2",
      "number": "33-53-2",
      "heading": "Conditions of coverage",
      "text": "An insurance policy that provides coverage for drugs may not exclude coverage of a covered drug on the grounds that the drug has not been approved by the federal Food and Drug Administration for the particular indication if any of the following conditions are met:(1)The drug is recognized for treatment of the indication in at least one standard reference compendium;(2)The drug is recommended for that particular type of cancer and found to be safe and effective in formal clinical studies, the results of which have been published in a peer reviewed professional medical journal published in either the United States or Great Britain.\n\nAn insurance policy that provides coverage for drugs may not exclude coverage of a covered drug on the grounds that the drug has not been approved by the federal Food and Drug Administration for the particular indication if any of the following conditions are met:(1)The drug is recognized for treatment of the indication in at least one standard reference compendium;(2)The drug is recommended for that particular type of cancer and found to be safe and effective in formal clinical studies, the results of which have been published in a peer reviewed professional medical journal published in either the United States or Great Britain.\n\nAn insurance policy that provides coverage for drugs may not exclude coverage of a covered drug on the grounds that the drug has not been approved by the federal Food and Drug Administration for the particular indication if any of the following conditions are met:(1)The drug is recognized for treatment of the indication in at least one standard reference compendium;(2)The drug is recommended for that particular type of cancer and found to be safe and effective in formal clinical studies, the results of which have been published in a peer reviewed professional medical journal published in either the United States or Great Britain.\n\nAn insurance policy that provides coverage for drugs may not exclude coverage of a covered drug on the grounds that the drug has not been approved by the federal Food and Drug Administration for the particular indication if any of the following conditions are met:",
      "history": "",
      "source_url": "https://law.justia.com/codes/georgia/title-33/chapter-53/section-33-53-2/"
    },
    {
      "id": "section-33-53-3",
      "number": "33-53-3",
      "heading": "[Reserved] Enforcement",
      "text": "Amended by 2019 Ga. Laws 186,§ 1-16, eff. 7/1/2019.\n\nAmended by 2019 Ga. Laws 186,§ 1-16, eff. 7/1/2019.\n\nAmended by 2019 Ga. Laws 186,§ 1-16, eff. 7/1/2019.\n\nAmended by 2019 Ga. Laws 186,§ 1-16, eff. 7/1/2019.",
      "history": "",
      "source_url": "https://law.justia.com/codes/georgia/title-33/chapter-53/section-33-53-3/"
    },
    {
      "id": "section-33-53-4",
      "number": "33-53-4",
      "heading": "Exceptions to requirements for coverage",
      "text": "This chapter shall not be deemed to do any of the following:(1)Require coverage for any drug when the federal Food and Drug Administration has determined the drug's use to be contraindicated;(2)Require coverage for an experimental drug not approved for any indication by the federal Food and Drug Administration;(3)Alter any other law limiting the coverage of drugs that have not been approved by the federal Food and Drug Administration.\n\nThis chapter shall not be deemed to do any of the following:(1)Require coverage for any drug when the federal Food and Drug Administration has determined the drug's use to be contraindicated;(2)Require coverage for an experimental drug not approved for any indication by the federal Food and Drug Administration;(3)Alter any other law limiting the coverage of drugs that have not been approved by the federal Food and Drug Administration.\n\nThis chapter shall not be deemed to do any of the following:(1)Require coverage for any drug when the federal Food and Drug Administration has determined the drug's use to be contraindicated;(2)Require coverage for an experimental drug not approved for any indication by the federal Food and Drug Administration;(3)Alter any other law limiting the coverage of drugs that have not been approved by the federal Food and Drug Administration.\n\nThis chapter shall not be deemed to do any of the following:",
      "history": "",
      "source_url": "https://law.justia.com/codes/georgia/title-33/chapter-53/section-33-53-4/"
    }
  ]
}